Bio-Matrix Scientific Group Chairman Sees Future of Stem Cell Therapies Focused on Stem Cell Repositories
September 30, 2010 08:00 ET
|
Entest BioMedical Inc.
SAN DIEGO, Sept. 30, 2010 (GLOBE NEWSWIRE) -- Bio-Matrix Scientific Group Inc. (OTCBB:BMSN) Chairman & CEO David Koos commented today about the future of stem cell therapy and how advances in...
Entest CEO Blogcast Today at 10:00 am Covering Strategic Rollout of ImenVax(TM) -- an Immuno-Therapeutic Cancer Vaccine for Dogs
September 21, 2010 08:00 ET
|
Entest BioMedical Inc.
Update to Include Strategy on Acquiring Veterinary Clinics for Immediate Revenue Generation and New Sales Channel for Veterinary Therapies
Blogcast Scheduled for Today, September 21st at 10:00 am...
Entest CEO to Conduct Blogcast on Strategic Rollout of ImenVax(TM), Company's Immuno-Therapeutic Cancer Vaccine for Dogs
September 16, 2010 08:00 ET
|
Entest BioMedical Inc.
Provides Update on Strategy to Acquire Veterinary Clinics for Immediate Revenue Generation and
New Sales Channel for Veterinary Therapies
Blogcast Scheduled for Tuesday, September 21st at 10:00...
Entest BioMedical has Identified Several Veterinary Clinics as Possible Acquisition Candidates to Serve as Distribution Channel for Veterinary Therapeutic Treatments
August 18, 2010 08:00 ET
|
Entest BioMedical Inc.
Clinics to Serve as Platform for Launching New 'Veterinary First' Pharmaceuticals
Entest Seeks to Acquire 5 Veterinary Clinics with a Total Target Revenue of Over $4 Million
SAN DIEGO –...
Entest BioMedical Finalizing Protocols for ImenVax(TM) Safety Study
July 29, 2010 09:00 ET
|
Entest BioMedical Inc.
Anticipates Commencing Study in Late September 2010
Represents Final Required Step Prior to Commercialization of Immuno-Therapeutic Cancer Vaccine for Dogs
SAN DIEGO , July 29, 2010 (GLOBE...
Entest BioMedical Retains Crescendo Communications as Investor Relations and Corporate Communications Advisor
July 27, 2010 09:04 ET
|
Entest BioMedical Inc.
SAN DIEGO, July 27, 2010 (GLOBE NEWSWIRE) -- Entest BioMedical Inc. (OTCBB:ENTB) today announced that it has retained Crescendo Communications, LLC ("Crescendo") as its investor relations firm to help...